Athens-Meeting-banner.jpg

Commercial Satellite Symposia

Thursday 27th September

Time: 14:00-15:00

Title: Small for Gestational Age: New Real World Evidence

14:00-14:05

Opening remarks

14:05-14:25

Diagnosis and management of a short child born Small for Gestational Age (SGA)

14:25-14:45

Long-term safety and metabolic outcomes of GH therapy in patients born Small for Gestational Age (SGA)

14:45-15:00

Panel discussion

 

Time: 18:30-20:00

Title: Diagnosis and lifespan care of children born SGA

18:30-18:35

Welcome and introduction

18:35-19:05

Diagnosis and management of defects of IGF-1 signalling

19:05-19:30

Diagnosis and management of imprinting disorders causing SGA

19:30-19:50

Lifespan metabolic consequences of SGA

19:50-20:00

Voting and closing remarks

 

Time: 18:30-20:00

Title: Finding solutions for Mucopolysaccharidosis type I diagnostic challenges

18:30-18:35

Opening

18:35-19:00

Need for early diagnosis of MPS I: newborn screening and its pitfalls, and the role of the family doctor

19:00-19:25

Development and testing of an easy-to-use clinical suspicion algorithm for MPS

19:25-19:50

Short stature and limited joint mobility may be indicative of MPS

19:50-20:00

Closing remarks

 

Time: 18:30-20:00

Title: Redefining XLH: a new targeted approach to improve outcomes

18:30-18:35

Welcome & introduction

18:35-18:50

XLH: disease overview and manifestations in children

18:50-19:05

Promoting early diagnosis in children with XLH

19:05-19:25

Challenges in the current management of children with XLH

19:25-19:45

Revolutionising the treatment of children with XLH

19:45-19:55

Audience Q&A

19:55-20:00

Summary & close

 

Friday 28th September

Time: 13:15-14:15

Title: Building blocks for effective GH treatment: dose, adherence and understanding our patients

13:15–13:20

Opening remarks

13:20–13:35

Does being taller equal feeling better in childhood?

13:35–13:50

Role of iGRO® in supporting treatment goals and adherence

13:50–14:05

Influence of GH treatment adherence to treatment outcomes

14:05–14:15

Q&A and meeting close

 

Time: 17:00-18:30

Title: New insights in Precocious Puberty

17:00-17:10

Welcome & introduction

17:10-17:35

Precocious puberty : diagnosis and genetic

17:35-18:00

Management and new treatment options

18:00-18:25

Debate: Diagnosis and treatment (pro-Contra debate)

18:25-18:30

Closing remarks

 

Time: 17:00-18:30

Title: Clinical approach to infants & children with short stature and suspected inherited skeletal disease

17:00-17:10

Clinical evaluation of infants and children with inherited forms of short stature

17:10-17:30

Radiological evaluation including differential diagnoses

17:30-17:50

Update and ongoing challenges in hypophosphatasia

17:50-18:10

Osteogenesis imperfecta – current paradigms, future directions

18:10-18:30

Q & A

 

Time: 17:00-18:30

Title: Identification of patients with rare genetic disorders of obesity

17:00-17:30

Critical genetic factors associated with rare genetic disorders of obesity

17:30-18:00

Using eating behavior phenotypes to tailor treatment

18:00-18:30

Burden of illness of obesity

 

Saturday 29th September

Time: 08:00-08:45

Title: Insulin Treatment and Advanced Technology in the Management of Children with Diabetes

08:00-08:05

Welcome

08:05-08:25

Insulin treatment in children with diabetes

08:25-08:40

Advanced technology in children with diabetes

08:40-08:45

Closing remarks

 

Time: 12:45-13:45

Title: Enhancing Quality of Care in Turner Syndrome and Diabetes Insipidus: Diagnostic and Treatment Dilemmas

12:45-12:50

Keynote opening – setting the stage

12:50-13:15

Challenges in Turner Syndrome – lessons from the 2017 Guidelines

13:15-13:35

Update in the Diagnosis and Management of Diabetes Insipidus

13:35-13:45

Discussions, Q&A